🔎 Trials Near Me

Home › Hip Injuries and Disorders › NCT03481010

Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

Recruiting

Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology: A Multicenter Randomized Controlled Trial

Who can join

Ages 16 to 50 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Skeletally mature patient undergoing Bernese periacetabular osteotomy for symptomatic acetabular dysplasia/hip instability
* Pre-Operative MRI at 3T and/or gadolinium MR arthrogram
* Age, 16-50 years old
* Patient capable of giving informed consent

Exclusion Criteria:

* Prior hip/pelvis surgery of any kind on the surgical side
* Prior hip arthroplasty surgery on either side
* Radiographic evidence of arthritis (i.e. Tönnis grade =2)
* Known connective tissue disorder (e.g. Ehlers-Danlos Syndrome, etc.)
* Known neuromuscular disorder (e.g. Cerebral Palsy, Spina bifida, etc.)
* Known skeletal dysplasia (e.g. Achondroplasia, Multiple Epiphyseal Dysplasia, etc.)
* Cognitive impairment that prevents accurate completion of patient-reported outcome questionnaires.
* Patient unable/unwilling to complete all required follow-up visits
* Concurrent proximal femoral osteotomy and/or surgical hip dislocation

About the study

At present, it is not clear whether performing a hip arthroscopy at the same time as a PAO improves patient outcomes after surgery compared to a PAO alone.

This research project will randomize patients to receive either a PAO alone, or a PAO and a hip arthroscopy at the same time.

What is being tested

Sponsor: Ottawa Hospital Research Institute · Participants: 204 · Started: Apr 4, 2018

Contact the study team

Official record on ClinicalTrials.gov — NCT03481010

Locations in the U.S.

IllinoisNorthwestern University, Chicago
MichiganWilliam Beaumont Hospital, Royal Oak
MissouriThe Washington University, St Louis
New YorkHospital for Special Surgery, New York

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.